SPARINGVISION
SparingVision is a biotechnology company focused on the discovery and development of innovative therapies for the treatment of blinding inherited retinal diseases. SparingVision is developing SPVN06, a gene-independent treatment for retinitis pigmentosa, the most common inherited retinal degeneration. There is currently no treatment to treat all genetic forms of this rare retinal disease that leads to blindness and affects nearly 2 million people worldwide.
SPARINGVISION
Industry:
Biotechnology Health Care Life Science
Founded:
2016-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.sparingvision.com
Total Employee:
1+
Status:
Active
Contact:
+33(0)1 43 46 20 60
Email Addresses:
[email protected]
Total Funding:
52.74 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Alkermes
Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-04-20 | GAMUT Therapeutics | GAMUT Therapeutics acquired by SparingVision | N/A |
Investors List
Intellia Therapeutics
Intellia Therapeutics investment in Corporate Round - SparingVision
Jeito Capital
Jeito Capital investment in Venture Round - SparingVision
Foundation Fighting Blindness
Foundation Fighting Blindness investment in Venture Round - SparingVision
4BIO Capital
4BIO Capital investment in Venture Round - SparingVision
Ysios Capital
Ysios Capital investment in Venture Round - SparingVision
UPMC Enterprises
UPMC Enterprises investment in Venture Round - SparingVision
Bpifrance
Bpifrance investment in Venture Round - SparingVision
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-09 | SparingVision Strengthens Leadership Team with the Appointment of Dr Mehdi Gasmi as Chief Operating Officer |
Official Site Inspections
http://www.sparingvision.com Semrush global rank: 9.41 M Semrush visits lastest month: 160
- Host name: 25.26.205.92.host.secureserver.net
- IP address: 92.205.26.25
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
